BiologicsMD Signs Deal to Make Its Osteoporosis Treatment

by Mark Carter  on Tuesday, Jun. 12, 2012 10:37 am   2 min read

BioMD President Paul Mlakar, left, with Ensysce Biosciences CEO Lynn Kirkpatrick.

BiologicsMD of Fayetteville has contracted for the manufacture of its osteoporosis treatment and welcomed a new board member to help guide it through the FDA approval process.

Want the Full Article?

Get Unlimited Archive Access for $19.95 per Year

Readers must pay to access stories older than 15 days.

Purchase Now

Already have archive access? Login to view this article.